bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Sept. 12, 2023
Abstract
Background
The
COVID-19
pandemic
caused
by
SARS-CoV-2
has
spread
rapidly
across
the
continents.
While
incidence
of
been
reported
to
be
higher
among
African-American
individuals,
rate
mortality
lower
compared
that
non-African-Americans.
ACE2
is
involved
in
as
uses
enzyme
enter
host
cells.
Although
difference
can
explained
many
factors
such
low
accessibility
health
insurance
community,
little
known
about
expression
patients
non-African-American
patients.
variable
genes
contribute
this
observed
phenomenon.
Methodology
In
study,
transcriptomes
from
and
were
retrieved
sequence
read
archive
analyzed
for
gene
expression.
HISAT2
was
used
align
reads
human
reference
genome,
HTseq-count
get
raw
counts.
EdgeR
utilized
differential
analysis,
enrichR
employed
enrichment
analysis.
Results
datasets
included
14
33
transcriptome
sequences
descent,
respectively.
There
24,092
differentially
expressed
genes,
with
7,718
upregulated
(log
fold
change
>
1
FDR
0.05)
16,374
downregulated
−1
0.05).
mRNA
level
found
considerably
cohort
(p-value
=
0.0242,
p-adjusted
value
0.038).
Conclusion
downregulation
could
indicate
a
correlation
severity
community.
EBioMedicine,
Journal Year:
2021,
Volume and Issue:
72, P. 103629 - 103629
Published: Oct. 1, 2021
The
COVID-19
pandemic
caused
by
the
Severe
Acute
Respiratory
Syndrome
Coronavirus-2
(SARS-CoV-2)
poses
an
unprecedented
challenge
to
humanity.
SARS-CoV-2
infections
range
from
asymptomatic
severe
courses
of
with
acute
respiratory
distress
syndrome
(ARDS),
multiorgan
involvement
and
death.
Risk
factors
for
disease
severity
include
older
age,
male
sex,
increased
BMI
pre-existing
comorbidities.
Ethnicity
is
also
relevant
susceptibility
severity.
Host
genetic
predisposition
now
increasingly
recognized
whole
genome
candidate
gene
association
studies
regarding
have
been
performed.
Several
common
rare
variants
in
genes
related
inflammation
or
immune
responses
identified.
We
summarize
research
on
host
genetics
compile
associated
discuss
that
should
be
investigated
further
understand
such
associations
provide
insights
pathogenesis,
risk
classification,
therapy
response,
precision
medicine,
drug
repurposing.
Cells,
Journal Year:
2023,
Volume and Issue:
12(5), P. 816 - 816
Published: March 6, 2023
The
development
of
long-term
symptoms
coronavirus
disease
2019
(COVID-19)
more
than
four
weeks
after
primary
infection,
termed
"long
COVID"
or
post-acute
sequela
COVID-19
(PASC),
can
implicate
persistent
neurological
complications
in
up
to
one
third
patients
and
present
as
fatigue,
"brain
fog",
headaches,
cognitive
impairment,
dysautonomia,
neuropsychiatric
symptoms,
anosmia,
hypogeusia,
peripheral
neuropathy.
Pathogenic
mechanisms
these
long
COVID
remain
largely
unclear;
however,
several
hypotheses
both
nervous
system
systemic
pathogenic
such
SARS-CoV2
viral
persistence
neuroinvasion,
abnormal
immunological
response,
autoimmunity,
coagulopathies,
endotheliopathy.
Outside
the
CNS,
SARS-CoV-2
invade
support
stem
cells
olfactory
epithelium
leading
alterations
function.
infection
may
induce
abnormalities
innate
adaptive
immunity
including
monocyte
expansion,
T-cell
exhaustion,
prolonged
cytokine
release,
which
cause
neuroinflammatory
responses
microglia
activation,
white
matter
abnormalities,
microvascular
changes.
Additionally,
clot
formation
occlude
capillaries
endotheliopathy,
due
protease
activity
complement
contribute
hypoxic
neuronal
injury
blood-brain
barrier
dysfunction,
respectively.
Current
therapeutics
target
pathological
by
employing
antivirals,
decreasing
inflammation,
promoting
regeneration.
Thus,
from
laboratory
evidence
clinical
trials
literature,
we
sought
synthesize
pathophysiological
pathways
underlying
potential
therapeutics.
International Journal of Molecular Sciences,
Journal Year:
2021,
Volume and Issue:
22(16), P. 8912 - 8912
Published: Aug. 18, 2021
The
year
2020
became
the
of
outbreak
coronavirus,
SARS-CoV-2,
which
escalated
into
a
worldwide
pandemic
and
continued
2021.
One
unique
symptoms
SARS-CoV-2
disease,
COVID-19,
is
loss
chemical
senses,
i.e.,
smell
taste.
Smell
training
one
methods
used
in
facilitating
recovery
olfactory
sense,
it
uses
essential
oils
lemon,
rose,
clove,
eucalyptus.
These
were
not
selected
based
on
their
constituents.
Although
scientific
studies
have
shown
that
they
improve
recovery,
there
may
be
better
combinations
for
recovery.
Many
phytochemicals
bioactive
properties
with
anti-inflammatory
anti-viral
effects.
In
this
review,
we
describe
compounds
anti-
inflammatory
effects,
list
plants
contain
these
compounds.
We
expand
review
from
terpenes
to
less
volatile
flavonoids
order
propose
combination
diets
can
develop
new
taste
method,
as
has
been
no
so
far.
Finally,
discuss
possible
use
clinical
settings.
Frontiers in Immunology,
Journal Year:
2022,
Volume and Issue:
13
Published: Feb. 17, 2022
Severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
is
responsible
for
the
current
disease
2019
(COVID-19)
pandemic,
affecting
more
than
219
countries
and
causing
death
of
5
million
people
worldwide.
The
genetic
background
represents
a
factor
that
predisposes
way
host
responds
to
SARS-CoV-2
infection.
In
this
sense,
variants
ACE
ACE2
could
explain
observed
interindividual
variability
COVID-19
outcomes.
order
improve
understanding
how
are
involved
in
severity
COVID-19,
we
included
total
481
individuals
who
showed
clinical
manifestations
were
diagnosed
by
reverse
transcription
PCR
(RT-PCR).
Genomic
DNA
was
extracted
from
peripheral
blood
saliva
samples.
insertion/deletion
polymorphism
evaluated
high-resolution
melting
method;
single-nucleotide
(SNP)
(rs4344)
SNPs
(rs2285666
rs2074192)
genotyped
using
TaqMan
probes.
We
assessed
association
polymorphisms
with
logistic
regression
analysis
adjusted
age,
sex,
hypertension,
type
diabetes,
obesity.
illness
our
study
population
divided
as
31%
mild,
26%
severe,
43%
critical
illness;
additionally,
18%
died,
whom
54%
male.
Our
results
codominant
model
contribution
gene
rs2285666
T/T
genotype
outcome
[odds
ratio
(OR)
=
1.83;
95%CI
1.01–3.29;
p
0.04]
require
oxygen
supplementation
(OR
1.76;
1.01–3.04;
0.04),
addition
strong
T
allele
variant
develop
male
1.81;
1.10–2.98;
0.02).
suggest
risk
severe
outcomes
especially
men,
regardless
obesity,
diabetes.
American Journal of Respiratory and Critical Care Medicine,
Journal Year:
2022,
Volume and Issue:
206(8), P. 961 - 972
Published: June 1, 2022
Rationale:
Autopsy
and
biomarker
studies
suggest
that
endotheliopathy
contributes
to
coronavirus
disease
(COVID-19)-associated
acute
respiratory
distress
syndrome.
However,
the
effects
of
COVID-19
on
lung
endothelium
are
not
well
defined.
We
hypothesized
is
caused
by
circulating
host
factors
direct
endothelial
infection
severe
syndrome
2
(SARS-CoV-2).
Objectives:
aimed
determine
SARS-CoV-2
or
sera
from
patients
with
permeability
inflammatory
activation
microvascular
cells.
Methods:
Human
cells
were
treated
live
SARS-CoV-2;
inactivated
viral
particles;
COVID-19,
without
healthy
volunteers.
Permeability
was
determined
measuring
transendothelial
resistance
electrical
current
flow,
where
decreased
signifies
increased
permeability.
Inflammatory
mediators
quantified
in
culture
supernatants.
Endothelial
biomarkers
patient
sera.
Measurements
Main
Results:
Viral
PCR
confirmed
enters
replicates
Live
SARS-CoV-2,
but
dead
virus
spike
protein,
induces
secretion
plasminogen
activator
inhibitor
1
vascular
growth
factor.
There
substantial
variability
different
donors.
Sera
induced
permeability,
which
correlated
severity.
Serum
levels
injury
severity
illness.
Conclusions:
infects
dysregulates
cell
functions.
Circulating
also
induce
dysfunction.
Our
data
point
roles
for
both
systemic
acting
COVID-19–associated
endotheliopathy.
Journal of Medical Virology,
Journal Year:
2023,
Volume and Issue:
95(4)
Published: April 1, 2023
Abstract
In
contemporary
literature,
little
attention
has
been
paid
to
the
association
between
coronavirus
disease‐2019
(COVID‐19)
and
cancer
risk.
We
performed
Mendelian
randomization
(MR)
investigate
causal
associations
three
types
of
COVID‐19
exposures
(critically
ill
COVID‐19,
hospitalized
respiratory
syndrome
2
(SARS‐CoV‐2)
infection)
33
different
cancers
European
population.
The
results
inverse‐variance‐weighted
model
indicated
that
genetic
liabilities
critically
had
suggestive
with
increased
risk
for
HER2‐positive
breast
(odds
ratio
[OR]
=
1.0924;
p
‐value
0.0116),
esophageal
(OR
1.0004;
0.0226),
colorectal
1.0010;
0.0242),
stomach
1.2394;
0.0331),
colon
1.0006;
0.0453).
1.1096;
0.0458),
1.0005;
0.0440)
as
well
1.3043;
0.0476).
SARS‐CoV‐2
infection
2.8563;
0.0019)
but
decreasing
head
neck
0.9986,
0.0426).
above
combinations
were
robust
through
test
heterogeneity
pleiotropy.
Together,
our
study
effects
on
Host
genetic
polymorphisms
are
recognized
as
a
critical
determinant
of
diversity
in
clinical
symptoms
Coronavirus
disease
2019
(COVID-19).
Accordingly,
this
study
aimed
to
determine
possible
associations
between
single
nucleotide
(SNPs)
37
candidate
variants
and
consequences
COVID-19
-
especially
long-term
symptoms,
Long
COVID.
A
total
260
patients,
divided
into
mild
(n
=
239)
severe
21)
further
categorized
based
on
the
presence
COVID
(no,
n
211;
yes,
49),
were
recruited.
Genotyping
selected
responsible
for
viral
entry,
immune
response,
inflammation
was
performed
using
MassARRAY
system.
Out
SNPs,
9
including
leucine
zipper
transcription
factor
like-1
(LZTFL1)
rs10490770
C
allele,
LZTFL1
rs11385942
dupA
nicotinamide
adenine
dinucleotide
synthetase-1
(NADSYN1)
rs12785878
TT
genotype,
plexin
A-4
(PLXNA4)
rs1424597
AA
rs17713054
interleukin-10
(IL10)
rs1800896
TC
genotype
angiotensin
converting
enzyme-2
(ACE2)
rs2285666
T
plasmanylethanolamine
desaturase-1
(PEDS1)
rs6020298
GG
G
allele
significantly
associated
with
an
increased
risk
developing
COVID,
whereas
receptor
subunit
beta
(IL10RB)
rs8178562
reduced
Kaplan-Meier
curve
displayed
that
above
gene
cumulative
rate
occurrence.
Polymorphisms
rs10490770,
rs11385942,
rs17713054,
NADSYN1
rs12785878,
PLXNA4
rs1424597,
IL10
rs1800896,
ACE2
rs2285666,
PEDS1
rs6020298,
IL10RB
appear
be
factors
involved
development
Heliyon,
Journal Year:
2024,
Volume and Issue:
10(9), P. e30208 - e30208
Published: April 25, 2024
The
rapid
emergence
of
multiple
strains
Severe
Acute
Respiratory
Syndrome
Coronavirus-2
(SARS-CoV-2)
has
sparked
profound
concerns
regarding
the
ongoing
evolution
virus
and
its
potential
impact
on
global
health.
Classified
by
World
Health
Organization
(WHO)
as
variants
concern
(VOC),
these
exhibit
heightened
transmissibility
pathogenicity,
posing
significant
challenges
to
existing
vaccine
strategies.
Despite
widespread
vaccination
efforts,
continual
SARS-CoV-2
presents
a
formidable
obstacle
achieving
herd
immunity.
Of
particular
is
coronavirus
spike
(S)
protein,
pivotal
viral
surface
protein
crucial
for
host
cell
entry
infectivity.
Mutations
within
S
have
been
shown
enhance
confer
resistance
antibody-mediated
neutralization,
undermining
efficacy
traditional
platforms.
Moreover,
undergoes
molecular
under
selective
immune
pressure,
leading
diverse
with
distinct
mutation
profiles.
This
review
underscores
urgent
need
vigilance
adaptation
in
development
efforts
combat
evolving
landscape
mutations
ensure
long-term
effectiveness
immunization
campaigns.
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
16
Published: Feb. 4, 2025
With
the
consistent
occurrence
of
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
infection,
prevalence
various
ocular
complications
has
increased
over
time.
SARS-CoV-2
infection
been
shown
to
have
neurotropism
and
therefore
lead
not
only
peripheral
inflammatory
responses
but
also
neuroinflammation.
Because
receptor
for
SARS-CoV-2,
angiotensin-converting
enzyme
(ACE2),
can
be
found
in
many
intraocular
tissues,
disease
2019
(COVID-19)
may
contribute
persistent
neuroinflammation,
microcirculation
dysfunction
symptoms.
Increased
awareness
neuroinflammation
future
research
on
interventional
strategies
are
important
improving
long-term
outcomes,
reducing
burden,
quality
life.
Therefore,
aim
this
review
is
focus
discuss
current
evidence
perspectives,
especially
possible
connections
between
conditions
potential
treatment
strategies.